Burstein Jennifer 4
4 · Stoke Therapeutics, Inc. · Filed Sep 12, 2019
Insider Transaction Report
Form 4
Burstein Jennifer
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2019-09-10+29,555→ 29,555 totalExercise: $28.80Exp: 2029-09-09→ Common Stock (29,555 underlying)
Footnotes (1)
- [F1]This option shall vest (i) 1/12th of the total shares on June 21, 2019; and then (ii) quarterly as to 1/12th of the total shares, commencing the first quarter following June 21, 2019, subject to reporting person's continued service through each vesting date.